New HIV vaccine shows unprecedented success in primate studies

The vaccine was developed through a 14-year collaboration led by scientists at La Jolla Institute for Immunology (LJI) and Scripps Research.

Highlights:

The researchers developed an HIV vaccine that trains immune cells to see past HIV's defenses.
The new HIV vaccine works by prompting the body's immune system to make high numbers of rarely seen "broadly neutralizing" antibodies.
In a recent pre-clinical trial, this vaccine resulted in the best HIV-fighting antibody response ever seen in primates.
The research suggests the new vaccine has the potential to protect humans from developing HIV infection and AIDS.

Source:

Journal reference: